TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive NCAB Plans Study Of Its Authorities. FDA, NIH To Provide $6.75 Million For Grants In Regulatory Science February 26, 2010
TCL Archive DCT Advisors OK 2 Grant Programs, Disapprove One, In NCI Effort To Improve Funding For Clinical Research March 8, 1991
